相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum Uric Acid and Diabetes: From Pathophysiology to Cardiovascular Disease
Niki Katsiki et al.
CURRENT PHARMACEUTICAL DESIGN (2021)
Uric acid and cardiovascular disease: A clinical review
Yuichi Saito et al.
JOURNAL OF CARDIOLOGY (2021)
Gout as a risk factor for acute myocardial infarction: evidence from competing risk model analysis
Chia-Luen Huang et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2021)
2020 American College of Rheumatology Guideline for the Management of Gout
John D. FitzGerald et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease
Claudio Borghi et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)
Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors
Mats Dehlin et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007-2016
Michael Chen-Xu et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer
Amar U. Kishan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Medication adherence among gout patients initiated allopurinol: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD)
Lieke E. J. M. Scheepers et al.
RHEUMATOLOGY (2018)
Medication adherence among patients with gout: A systematic review and meta-analysis
Lieke E. J. M. Scheepers et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2018)
Determinants of hyperuricemia in non-dialysed chronic kidney disease patients in three hospitals in Cameroon
Marie Doualla et al.
BMC NEPHROLOGY (2018)
Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study
Hisashi Yamanaka et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
2016 updated EULAR evidence-based recommendations for the management of gout
P. Richette et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Matching Weights to Simultaneously Compare Three Treatment Groups Comparison to Three-way Matching
Kazuki Yoshida et al.
EPIDEMIOLOGY (2017)
The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012
Sharan K. Rai et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Association of Coffee Consumption With Total and Cause-Specific Mortality Among Nonwhite Populations
Song-Yi Park et al.
ANNALS OF INTERNAL MEDICINE (2017)
Adherence with urate-lowering therapies among male patients with gout in a routine clinical setting
Sunggun Lee et al.
MODERN RHEUMATOLOGY (2016)
Adherence and persistence to urate-lowering therapies in the Irish setting
Bernie McGowan et al.
CLINICAL RHEUMATOLOGY (2016)
2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
Tuhina Neogi et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Safety profile of anti-gout agents: an update
Lisa K. Stamp
CURRENT OPINION IN RHEUMATOLOGY (2014)
Pharmacokinetics considerations for gout treatments
Pascal Richette et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2014)
Risk of myocardial infarction among patients with gout: a nationwide population-based study
Chang-Fu Kuo et al.
RHEUMATOLOGY (2013)
Rates of adherence and persistence with allopurinol therapy among gout patients in Israel
Gisele Zandman-Goddard et al.
RHEUMATOLOGY (2013)
Acute colchicine overdose: report of three cases
A. Aghabiklooei et al.
REUMATISMO (2013)
Risk of end-stage renal disease associated with gout: a nationwide population study
Kuang-Hui Yu et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Unrecognized fatalities related to colchicine in hospitalized patients
Michael Mullins et al.
CLINICAL TOXICOLOGY (2011)
An overview of the objectives of and the approaches to propensity score analyses
Georg Heinze et al.
EUROPEAN HEART JOURNAL (2011)
An Allopurinol-Controlled, Randomized, Double-Dummy, Double-Blind, Parallel Between-Group, Comparative Study of Febuxostat (TMX-67), a Non-Purine-Selective Inhibitor of Xanthine Oxidase, in Patients With Hyperuricemia Including Those With Gout in Japan
Naoyuki Kamatani et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2011)
Colchicine poisoning: the dark side of an ancient drug
Yaron Finkelstein et al.
CLINICAL TOXICOLOGY (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Determinants of the clinical outcomes of gout during the first year of urate-lowering therapy
Michael A. Becker et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2008)
Comparison of drug adherence rates among patients with seven different medical conditions
Becky A. Briesacher et al.
PHARMACOTHERAPY (2008)
Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: A retrospective study
IFN Hung et al.
CLINICAL INFECTIOUS DISEASES (2005)
分享论文
